A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1997
12/03/1997	EP0590055B1 M-protein peptides of influenza virus as antiviral agents
12/03/1997	CN1166831A Novel benzyl pyrimidines
12/03/1997	CN1166786A Retroviral protease inhibitor combinations
12/03/1997	CN1166317A Compound women's moistening cleaner
12/03/1997	CN1036592C Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/03/1997	CN1036587C Process for preparation of cephalosporin antibiotic
12/02/1997	US5693827 Treatment of HIV infections and compounds useful therein
12/02/1997	US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole
12/02/1997	US5693814 Crystals of antimicrobial compound
12/02/1997	US5693803 Epoxide intermediates formed by reacting amine nucleophile with activated glycidyl derivative
12/02/1997	US5693800 N-(2-amino-4,6-dichloropyrimidine-5-yl) formamide and a process for its preparation
12/02/1997	US5693790 Crystalline form of a cephalosporin antibiotic
12/02/1997	US5693787 Stereospecific
12/02/1997	US5693772 Desalaninebenanomicin A derivatives and processes for the preparation thereof
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693752 Hexapeptides of specified amino acid sequences
12/02/1997	US5693750 Microbiocidal action against pneumocystis infections
12/02/1997	US5693661 Viricides against rhinoviruses, picornaviruses
12/02/1997	US5693634 For systemic and topical treatment of humans and animals; veterinary medicine
12/02/1997	US5693626 Treating or preventing fungal infections by oral or parenteral administration
12/02/1997	US5693621 Inhibiting binding of selectin to carbohydrate ligands
12/02/1997	US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	US5693530 Recombinant vectors; vaccines
11/1997
11/27/1997	WO1997044354A2 Synthesis of soluble beta-sheet forming peptides
11/27/1997	WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997	WO1997044349A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
11/27/1997	WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	WO1997044047A1 Composition and method for treating herpes simplex
11/27/1997	WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997	WO1997044032A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
11/27/1997	WO1997044006A1 Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and textile fibre materials
11/27/1997	WO1997043901A1 IceA GENE AND RELATED METHODS
11/27/1997	WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997	DE19620644A1 Verwendung von stickstoffhaltigen Komplexbildnern zur Desodorierung und antimikrobiellen Behandlung der Haut und textilen Fasermaterialien The use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and of textile fiber materials
11/27/1997	CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	CA2256465A1 Blocking expression of virulence factors in s. aureus
11/27/1997	CA2253934A1 Inhibitors of protein farnesyl transferase
11/27/1997	CA2227171A1 Icea gene and related methods
11/26/1997	EP0808846A2 Peptides which react with antiboby representing the prognostic marker for HIV disease progression
11/26/1997	EP0808330A1 A process for preparing certain aza cyclohexapeptides
11/26/1997	EP0808326A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
11/26/1997	EP0808322A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF
11/26/1997	EP0808315A1 Carbapenem-3-carboxylic acid ester derivatives
11/26/1997	EP0808173A2 Product and method for preventing respiratory virus infection
11/26/1997	EP0808168A1 Pharmaceutical composition for the treatment of herpes
11/26/1997	EP0691977B1 Oligonucleotides with amide linkages replacing phosphodiester linkages
11/26/1997	CN1036522C Improved meningococcal polysaccharide conjugate vaccine
11/26/1997	CN1036504C Improved meningococoal polysaccharide conjugate vaccine prepn. method
11/25/1997	US5691372 Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
11/25/1997	US5691349 Quinclidine derivatives as squalene synthase inhibitors
11/25/1997	US5691304 Improved process for preparing polymyxin B/dextran conjugates
11/25/1997	US5691132 Method for inactivating pathogens in red cell compositions using quinacrine mustard
11/25/1997	US5690940 Low pathogencity PRRS live virus vaccines and methods of preparation thereof
11/25/1997	US5690937 Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
11/25/1997	US5690930 Anticarcinogenic and antipsoriasis agents; viricides
11/25/1997	CA2113567C Benzimidazole anthelmintics
11/22/1997	CA2205077A1 Peptides which react with antibody representing the prognostic marker for hiv disease progression
11/20/1997	WO1997043310A1 Synthetic inhibitors of hepatitis c virus ns3 protease
11/20/1997	WO1997043305A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997	WO1997043280A1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
11/20/1997	WO1997043277A1 2,4-diaminopyrimidine derivatives
11/20/1997	WO1997043266A1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
11/20/1997	WO1997043258A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997042979A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	WO1997042972A1 Attenuated canine parvovirus vaccine
11/20/1997	WO1997042969A1 USE OF IL-12 AND IFN-α FOR THE TREATMENT OF INFECTIOUS DISEASES
11/20/1997	WO1997042968A2 Administration of histamine for therapeutic purposes
11/20/1997	WO1997042966A1 Therapeutic uses of bpi protein products for human meningococcemia
11/20/1997	WO1997042962A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/1997	WO1997042954A1 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	WO1997042939A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/20/1997	WO1997042825A1 Antimicrobial peroxidase compositions
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	DE19632823C1 Complexes of (+)-S-adenosyl-methionine and 3'-azido-2',3'-di:deoxy nucleoside compounds
11/20/1997	CA2254343A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
11/20/1997	CA2254126A1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
11/20/1997	CA2254122A1 Synthetic inhibitors of hepatitis c virus ns3 protease
11/20/1997	CA2253652A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/20/1997	CA2253365A1 Administration of histamine for therapeutic purposes
11/19/1997	EP0807687A2 Herpesviral proteases, compositions capable of binding them and uses thereof.
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807439A2 Method of treating sepsis and adult respiratory distress syndrome
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807178A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
11/19/1997	EP0807124A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
11/19/1997	EP0807112A1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997	EP0806954A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
11/19/1997	EP0806943A1 Valaciclovir tablets containing colloidal silicon dioxide
11/19/1997	EP0806941A1 Low rigidity liposomal antibacterial composition
11/19/1997	EP0806935A2 Anti-adhesive active principles
11/19/1997	EP0754188B1 Oligonucleotides with anti-cytomegalovirus activity
11/19/1997	EP0731807A4 N-2 substituted purines
11/19/1997	EP0720604B1 Conformationally locked nucleoside analogues

1 ... 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 ... 1798